-
Hybribio to Exhibit at MEDICA 2023
[Guangdong, 1 November 2023] Hybribio is excited to announce its participation in the upcoming MEDICA 2023 taking place in Düsseldorf, Germany from 13th November to 16th November. MEDICA, as one of th
2023-11-01 凯普生物 153
-
Meet Hybribio at TIF 2023
The 16th International Conference on Thalassaemia and Other Haemoglobinopathies & 18th TIF Conference for Patients and Parents will take place on 3-5 November 2023, at the Grand Hyatt Hotel, Kuala
2023-10-15 凯普生物 302
-
New Product Launch - ApoE and SLCO1B1 Gene MCA Real-time PCR Kit
Recently, Hybribio ApoE and SLCO1B1 Gene MCA Real-time PCR Kit (Fluorescence PCR melting curve method) has been approved by the National Medical Products Administration (NMPA) and obtained a Class III
2023-09-06 凯普生物 144
-
New Product Launch - Hybribio MTHFR Gene MCA Real-time PCR Kit Approved by NMPA
In August 17, 2023, Hybribio Biotech’s independently developed MTHFR Gene MCA Real-time PCR Kit (fluorescence PCR melting curve method) was officially awarded a Class III medical device registration c
2023-08-18 凯普生物 137
-
Hybribio showcased cutting-edge cervical cancer HPV diagnostic solutions at ADLM 2023
Hybribio (300639.SZ) exhibited live at the 75th ADLM (former AACC) Annual Scientific Meeting & Clinical Lab Expo, July 25-27, at Anaheim Convention Center, California, USA. This event attracted 95
2023-08-02 凯普生物 305
-
Hybribio to showcase latest nucleic acid diagnostic solutions at 2023 AACC Clinical Lab Expo
Hybribio (300639, SZ) will be at 2023 American Association of Clinical Chemistry (AACC) Scientific Meeting and Clinical Lab Expo, July 25-27 in Anaheim, California, USA. The Hybribio exhibit booth (No
2023-07-27 凯普生物 189